Citations 2

DURABLES RESPONSES WITH ANTI‐CD19 ALLOGENEIC CAR T ALLO‐501/501A IN PHASE 1 TRIALS OF RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA (R/R LBCL)

Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 85-86

10.1002/hon.3163_48

LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN R/R CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): PRIMARY ANALYSIS OF TRANSCEND CLL 004

Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 60-62

10.1002/hon.3163_26